Medical Pharmaceuticals

Huma receives multi-condition US FDA 510(k) Class II regulatory clearance for its configurable SaMD disease management platform

by

Class II clearance expands the patient population that can be managed  Companies working with Huma’s platform can now launch algorithm innovations more quickly in a compliant and de-risked manner, democratising digital health innovation across the industry Clearance was granted through the FDA’s joint eSTAR programme which aims to increase the efficiency of regulation through digitalisation NEW YORK … Read more

Successfully Concludes, Setting New Milestones in Allergy and Clinical Immunology

by

HAMBURG, Germany, June 12, 2023 /PRNewswire/ — The European Academy of Allergy and Clinical Immunology (EAACI) is pleased to announce the successful conclusion of its highly anticipated Annual Congress, held in Hamburg, Germany, from June 9 to 11. The congress brought together a distinguished gathering of leading experts, healthcare professionals, researchers, and industry representatives from … Read more

Translumina bolsters its German presence with acquisition of Lamed GmbH

by

NEW DELHI and MUNICH, June 12, 2023 /PRNewswire/ — Translumina, a global leader in interventional cardiovascular medical devices with manufacturing presence in Germany and India, today announced the acquisition of Munich-based Lamed GmbH. With this acquisition, Translumina has taken a step further towards its stated goal of providing a comprehensive cardiovascular portfolio at scale across … Read more

Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline at 2023 ASCO Annual Meeting

by

— Breadth of pipeline featured in multiple early clinical data presentations, reflecting diversity of fundamental growth drivers across development programs — CAMBRIDGE, Mass., June 3, 2023 /PRNewswire/ — Blueprint Medicines Corporation (Nasdaq: BPMC) today announced clinical data for multiple programs across its precision therapy portfolio at the 2023 American Society of Clinical Oncology (ASCO) Annual … Read more

Increasing Prevalence of Diseases is a Major Driver

by

DUBLIN, June 2, 2023 /PRNewswire/ — The “Small Molecule Active Pharmaceutical Ingredient Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global small molecule active pharmaceutical ingredient market is expected to grow from $167.59 billion … Read more

Global Microbiome Partnering Terms and Agreements 2010 to 2023

by

DUBLIN, June 2, 2023 /PRNewswire/ — The “Global Microbiome Partnering Terms and Agreements 2010 to 2023” report has been added to  ResearchAndMarkets.com’s offering. This report provides an understanding and access to the microbiome partnering deals and agreements entered into by the world’s leading healthcare companies. Trends in microbiome partnering deals Disclosed headlines, upfronts, milestones and … Read more

FDA Roundup: June 2, 2023

by

SILVER SPRING, Md., June 2, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA provided an update on medical device reports it received that are reportedly associated with the breakdown or suspected breakdown of the polyester-based polyurethane (PE-PUR) foam used … Read more

Hauptsitz, Forschung und Entwicklung und Produktionsstätte von Scivita Medical offiziell eröffnet

by

SUZHOU, China, 2. Juni 2023 /PRNewswire/ — Am 2. Juni 2023 (Zeit Peking) wurden der Hauptsitz, die Forschungs- und Entwicklungsabteilung und die Produktionsstätte von Scivita Medical offiziell im Suzhou Industrial Park (SIP) eröffnet. Dieser bedeutsame Anlass ist ein wichtiger Meilenstein für Scivita Medical, denn das Unternehmen bündelt seine wichtigsten Aktivitäten in den Bereichen Forschung und … Read more

Study Helps Explain What Drives Psoriasis Severity and Offers Clues as to How Disease May Spread to Other Body Parts

by

NEW YORK, June 2, 2023 /PRNewswire/ — Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told apart by the activity of key cells and signaling pathways, a new study shows. Led by researchers at NYU Grossman School of … Read more

PCOM South Georgia graduates inaugural class of osteopathic physicians

by

MOULTRE, Ga., June 2, 2023 /PRNewswire/ — To the cheers of family and friends, the first class of PCOM South Georgia students to earn the doctor of osteopathic medicine degree graduated on Thursday, May 25, at the UGA Conference Center in Tifton along with the second class to earn the master of science degree in biomedical … Read more